HDR Brachytherapy as Monotherapy for Prostate Cancer: Early Toxicity of a Randomized Phase II Trial

被引：0
|
作者：
Jolicoeur, M. [1 ]
Derashodian, T. [1 ]
Nguyen-Huynh, T. [1 ]
Hillmann, E. de Castro [1 ]
Berbiche, D. [2 ]
Truchon, D. [1 ]
Heliou, R. [1 ]
Mondat, M. [1 ]
机构：
[1] Charles LeMoyne Hosp, Radiol Oncol, Greenfield Pk, PQ, Canada
[2] Charles LeMoyne Hosp, Ctr Rech, Greenfield Pk, PQ, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2021年 / 158卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP-0121
引用
收藏
页码：S90 / S91
页数：2
相关论文
共 50 条
  • [21] Interstitial high dose rate (HDR) brachytherapy monotherapy for early stage prostate cancer
    Neumann, T
    Mark, RJ
    Vallabhan, G
    Anderson, PJ
    Akins, RS
    Nair, M
    White, D
    Steven, G
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S452 - S452
  • [22] Dosimetric quality and acute toxicity in HDR-brachytherapy as monotherapy in low risk prostate cancer
    Isaak, B
    Thalmann, G
    Vock, J
    Rentsch, CA
    Manser, P
    Mini, R
    Greiner, RH
    Kolotas, C
    Aebersold, D
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 : 131 - 131
  • [23] HDR brachytherapy as monotherapy for low and intermediate risk prostate cancer
    Gaudet, M.
    Pharand-Charbonneau, M.
    Wright, D.
    Desrosiers, M.
    Haddad, A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S1188 - S1188
  • [24] HDR brachytherapy combined to EBRT for prostate cancer: analysis of toxicities and PSA bounce of a phase II trial
    Tetreault-Laflamme, A.
    Nguyen, T. V.
    Vincent, F.
    Saad, F.
    Benoit, N.
    Fortin, B.
    Lambert, C.
    Jolicoeur, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S566 - S566
  • [25] MR-Guided HDR Brachytherapy Boost in Localized Prostate Cancer Results of a Phase II Trial
    Johnny, C.
    Berlin, A.
    Weersink, R. A.
    Raman, S.
    Glicksman, R.
    Catton, C.
    Rink, A.
    Warde, P. R.
    Lao, B.
    Menard, C.
    Chung, P.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E397 - E397
  • [26] A 7 YEAR EXPERIENCE OF PROSTATE HDR BRACHYTHERAPY AS MONOTHERAPY: ANALYSIS OF OUTCOME AND TOXICITY
    Sacco, S.
    D'Amico, R.
    Frigerio, C.
    Sangalli, G.
    Declich, F.
    Colombo, A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S279 - S279
  • [27] Intraoperative real-time planning for HDR brachytherapy as monotherapy in early stage prostate cancer
    Martin, T
    Baltas, D
    Kurek, R
    Röddiger, S
    Buhleier, T
    Tunn, UW
    Zamboglou, N
    [J]. RADIOTHERAPY AND ONCOLOGY, 2004, 71 : S45 - S45
  • [28] GENITOURINARY TOXICITY IN PROSTATE HDR BRACHYTHERAPY
    Aleknavicius, E.
    Burneckis, A.
    Ivanauskas, A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S381 - S382
  • [29] Interstitial high dose rate (HDR) brachytherapy plus IMRT vs. HDR monotherapy for early stage prostate cancer
    Neumann, T.
    Mark, R.
    Anderson, P.
    White, D.
    Gurley, S.
    Akins, R.
    Nair, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S448 - S448
  • [30] Interstitial high dose rate (HDR) brachytherapy plus IMRT vs. HDR monotherapy for early stage prostate cancer
    Neumann, T
    Mark, R
    Akins, S
    Nair, M
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S313 - S314
12345